Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -19.70%-19.06M | 10.20%-33.37M | 11.92%-15.92M | -17.21%-37.16M | 9.16%-18.07M | 19.71%-31.7M | -14.70%-19.9M | -26.88%-39.48M | -51.36%-17.35M | -604.32%-31.12M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 13.73%-88K | 65.65%-191K | 73.98%-102K | 34.36%-556K | -3.43%-392K | 47.97%-847K | 66.10%-379K | -18.66%-1.63M | -168.11%-1.12M | -209.01%-1.37M |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---5.22M | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | -43.20%355K | -43.11%355K | -47.12%625K | 37.44%624K | 1,937.93%1.18M |
| Impairment and provisions: | ---- | ---- | ---- | ---- | ---- | -63.21%1.1M | --1.1M | -46.61%2.99M | ---- | --5.6M |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | -63.21%1.1M | --1.1M | -46.61%2.99M | ---- | --5.6M |
| Asset sale loss (gain): | ---- | ---- | ---- | -21,380.00%-4.3M | ---4.3M | ---20K | ---- | ---- | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | -21,380.00%-4.3M | ---4.3M | ---20K | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | -9.39%6.89M | -5.64%14.39M | -0.92%7.61M | 175.17%15.25M | 149.77%7.68M | -15.88%5.54M | -9.35%3.07M | -30.40%6.59M | -27.91%3.39M | 21.97%9.47M |
| -Other depreciation and amortization | -40.37%842K | -28.19%2.03M | -0.21%1.41M | 80.32%2.83M | 78.66%1.42M | -12.04%1.57M | -12.58%792K | -47.79%1.79M | -47.02%906K | 82.64%3.42M |
| Financial expense | 156.49%4.59M | 37.62%3.72M | 13.74%1.79M | -51.29%2.71M | -29.92%1.57M | -8.54%5.56M | -24.86%2.24M | 112.45%6.07M | 228.38%2.99M | 369.46%2.86M |
| Exchange Loss (gain) | -124.90%-262K | -214.10%-356K | 249.50%1.05M | 647.37%312K | 115.00%301K | -139.04%-57K | -7.89%140K | 417.39%146K | 65.22%152K | 0.00%-46K |
| Special items | -13.74%609K | -26.94%686K | --706K | 187.59%939K | ---- | ---1.07M | ---- | ---- | ---- | ---194K |
| Operating profit before the change of operating capital | -50.32%-7.32M | 33.71%-15.12M | 63.14%-4.87M | 13.50%-22.8M | 1.14%-13.21M | -6.78%-26.36M | -18.13%-13.36M | -81.23%-24.69M | -97.81%-11.31M | -486.99%-13.62M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | -101.37%-614K | 307.01%47.01M | 696.47%44.95M | -189.56%-22.71M | 51.17%5.64M | -206.23%-7.84M | 49.02%3.73M | 172.83%7.38M | 130.40%2.51M | -133.56%-10.14M |
| Accounts payable increase (decrease) | 113.11%5.75M | -174.94%-37.46M | -704.22%-43.82M | 801.52%49.98M | 641.27%7.25M | 50.00%5.54M | -108.04%-1.34M | -9.52%3.7M | 768.83%16.67M | 111.67%4.09M |
| Special items for working capital changes | -99.23%28K | 248.28%1.33M | 694.74%3.62M | -51.09%-899K | 6,414.29%456K | -14,775.00%-595K | -81.08%7K | -100.29%-4K | -97.33%37K | 705.70%1.38M |
| Cash from business operations | -1,640.32%-2.16M | -218.41%-4.23M | -187.94%-124K | 112.20%3.57M | 101.29%141K | -114.92%-29.26M | -238.73%-10.96M | 25.59%-13.61M | 152.46%7.9M | -1,113.93%-18.29M |
| Other taxs | ---- | 174.49%625K | ---- | -399.40%-839K | ---- | -140.00%-168K | ---- | 64.10%-70K | ---- | 90.08%-195K |
| Interest received - operating | -56.86%88K | -87.87%191K | -81.30%204K | 148.26%1.57M | 114.34%1.09M | -62.31%634K | -53.98%509K | 140.63%1.68M | 1,806.90%1.11M | 170.93%699K |
| Interest paid - operating | ---- | -822.58%-286K | 80.65%-222K | 94.48%-31K | -220.39%-1.15M | 50.40%-562K | 49.29%-358K | -159.27%-1.13M | -6,318.18%-706K | 28.24%-437K |
| Net cash from operations | -1,357.75%-2.07M | -186.49%-3.7M | -267.06%-142K | 114.55%4.27M | 100.79%85K | -123.49%-29.35M | -230.23%-10.81M | 27.95%-13.13M | 155.29%8.3M | -376.65%-18.23M |
| Cash flow from investment activities | ||||||||||
| Purchase of fixed assets | 39.06%-638K | -117.98%-4M | 16.71%-1.05M | 45.14%-1.84M | -31.76%-1.26M | -191.12%-3.35M | -38.66%-954K | -48.07%-1.15M | -16.41%-688K | 80.80%-776K |
| Purchase of intangible assets | ---- | -93.10%-56K | ---- | ---29K | ---- | ---- | ---- | ---12M | ---12M | ---- |
| Sale of subsidiaries | ---- | ---- | ---- | ---147K | ---147K | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 39.06%-638K | -101.69%-4.06M | 25.43%-1.05M | 39.88%-2.01M | -47.17%-1.4M | 74.56%-3.35M | 92.48%-954K | -1,594.46%-13.15M | -2,046.87%-12.69M | 92.61%-776K |
| Net cash before financing | -127.75%-2.71M | -442.81%-7.75M | 9.86%-1.19M | 106.92%2.26M | 88.79%-1.32M | -24.40%-32.7M | -168.35%-11.77M | -38.30%-26.28M | 71.91%-4.39M | -32.60%-19M |
| Cash flow from financing activities | ||||||||||
| Issuing shares | ---- | 32.64%7.8M | ---- | -68.22%5.88M | --5.88M | 19.78%18.51M | ---- | 33.87%15.45M | ---- | --11.54M |
| Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --15M | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | -205.20%-13.73M | -81.38%-8.16M | ---4.5M | ---4.5M | ---- | ---- | ---- |
| Net cash from financing operations | -9.13%-490K | 180.41%7.07M | 83.55%-449K | -168.80%-8.79M | 47.94%-2.73M | -56.14%12.77M | -831.44%-5.24M | 186.46%29.12M | -105.20%-563K | 807.80%10.16M |
| Effect of rate | -84.18%59K | 462.71%214K | 732.20%373K | 87.45%-59K | 89.77%-59K | 28.90%-470K | 38.68%-577K | -156.93%-661K | -213.24%-941K | 953.68%1.16M |
| Net Cash | -95.24%-3.2M | 89.50%-685K | 59.55%-1.64M | 67.25%-6.53M | 76.20%-4.05M | -803.07%-19.93M | -243.80%-17.01M | 132.06%2.83M | -3.43%-4.95M | 43.94%-8.84M |
| Begining period cash | -10.63%3.96M | -59.78%4.43M | -59.78%4.43M | -64.93%11.02M | -64.93%11.02M | 7.43%31.41M | 7.43%31.41M | -20.80%29.24M | -20.80%29.24M | -30.11%36.92M |
| Cash at the end | -74.09%820K | -10.63%3.96M | -54.18%3.17M | -59.78%4.43M | -50.03%6.91M | -64.93%11.02M | -40.80%13.82M | 7.43%31.41M | -29.17%23.35M | -20.80%29.24M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.